Charles River Laboratories International Inc (NYSE:CRL)
| 432.37 Delayed Data As of 4:15pm ET |  -25.93 / -5.66%Today’s Change | 219.09 Today|||52-Week Range 460.21 | +73.04% Year-to-Date |
Latest CRL News | Press Releases
| Donoghue Forlines Momentum Fund Buys Bruker Corp, Charles River Laboratories International Inc, ... Sep 22 / GuruFocus News - Paid Partner Content | Here's Why You Should Invest in Charles River (CRL) Now Sep 14 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 458.30 |
| Today’s open | 455.39 |
| Day’s range | 426.59 - 455.44 |
| Volume | 646,380 |
| Average volume (3 months) | 376,913 |
| Market cap | $23.1B |
Data as of 4:15pm ET, 09/27/2021
Growth & Valuation
| Earnings growth (last year) | +42.16% |
| Earnings growth (this year) | +26.95% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | +11.55% |
| P/E ratio | 55.7 |
| Price/Sales | 4.36 |
| Price/Book | 10.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICLRICON PLC | -11.94 | -4.22% |
| ---- | ||
| SYNHSyneos Health Inc | -1.87 | -1.94% |
| MEDPMedpace Holdings Inc | -7.17 | -3.62% |
Data as of 4:14pm ET, 09/27/2021
Financials
| Next reporting date | November 10, 2021 |
| EPS forecast (this quarter) | $2.59 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | $364.3M |
| Net profit margin | 12.46% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Wilmington, Massachusetts |
Forecasts
